ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

HEMO Hemogenyx Pharmaceuticals Plc

1.31
0.02 (1.55%)
28 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hemogenyx Pharmaceuticals Plc LSE:HEMO London Ordinary Share GB00BYX3WZ24 ORD GBP0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.02 1.55% 1.31 1.282 1.338 1.326 1.272 1.29 5,347,757 16:35:08
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Finance Services 0 -6.69M -0.0050 -2.60 17.44M
Hemogenyx Pharmaceuticals Plc is listed in the Finance Services sector of the London Stock Exchange with ticker HEMO. The last closing price for Hemogenyx Pharmaceuticals was 1.29p. Over the last year, Hemogenyx Pharmaceuticals shares have traded in a share price range of 1.25p to 6.30p.

Hemogenyx Pharmaceuticals currently has 1,341,815,988 shares in issue. The market capitalisation of Hemogenyx Pharmaceuticals is £17.44 million. Hemogenyx Pharmaceuticals has a price to earnings ratio (PE ratio) of -2.60.

Hemogenyx Pharmaceuticals Share Discussion Threads

Showing 2401 to 2424 of 13450 messages
Chat Pages: Latest  106  105  104  103  102  101  100  99  98  97  96  95  Older
DateSubjectAuthorDiscuss
22/4/2020
11:33
Er, this company is nothing to do with covid 😂
davevt
22/4/2020
11:33
digitt,

The RNS mentions that this is concurrent to the other projects, which we know are in the hands of Orgenesis/Belgian government and Globalco(s)

"This development is an application of the Company's existing work, taking place alongside its long-term development of new treatments for blood and autoimmune diseases, which remain on track. "

on target
22/4/2020
11:32
take a look at other covid 19 stocks - mkt cap tiny here.
pre
22/4/2020
11:31
Big news? What are you talking about? It's only a patent issuance, and Cornell own the patent.
davevt
22/4/2020
11:31
Words from the most infamous deramper....something must be wrong today lol
zen12
22/4/2020
11:30
That's exactly what I invested in and am waiting for, and have had the same concerns as many on lack of comms from the company. But I worry the COVID stuff is purely jumping on the bandwagon to get a share price back to where it was a year or so ago, with nothing really behind it. ie so likely to unwind, while at the same time possibly distracting us from the initial plan.

Will be ecstatic to be proven wrong and do enjoy being less out of the money though.

I'm still waiting for my Kickstarter humanized mouse to arrive in the post.

digittt
22/4/2020
11:29
Overhang 2.2p to buy when 2.2-2.35p spread

but it's going to clear quickly at this rate buys are flying in

dave4545
22/4/2020
11:29
big news for such a small cap, this will follow others involved in covid 19, start of the journey..100k buys
pre
22/4/2020
11:26
Ohh and here is yesterdays seller diddums
knowing
22/4/2020
11:26
On Target - my buy price at 1.7p
sell few at 2.15
few at 2.1

But as i say, i learned.

if you wont sell then this back to 1.5 or even 1P

idontflykathyy
22/4/2020
11:25
LOL W*nker
knowing
22/4/2020
11:24
Nothing concrete discovered
costax1654x
22/4/2020
11:24
LOL, poor Kathy has sold at the wrong time again.
on target
22/4/2020
11:23
digitt

Did you see Nsci Rns, there's was nothing much and it went from 5p to 20p...of course it went all the way back down too but the momentum could take this to 5p later on

dave4545
22/4/2020
11:22
Those who wont sell in this opportunity must themselves to blame.
I repeast - READ RNS AGAIN


NOTHING!!!!

idontflykathyy
22/4/2020
11:19
I just sold a nice little chunk at 2.2
davevt
22/4/2020
11:19
Not to mention AML and bone marrow treatment (no more chemo/radiotherapy) CDX which is approaching clinical trial ready. Just waiting for 'globalco' licencing RNS on that and ££££.
on target
22/4/2020
11:18
Am I missing something or is the RNS not saying much? Just that Hemo will work on something. Nothing concrete discovered in essence?

As jaded and cynical as I sound, this bump finally puts me in positive territory after a long hold, so I'm happy...I'm just confused and about to give up trying to interpret this market.

Made the mistake of looking at the live price and now I'm in the red again...boo!

digittt
22/4/2020
11:18
Very low mcap for current patents. Future patents and potential of its mice.
orchestralis
22/4/2020
11:16
Plus the 36.000.000 mil Placing at 1.8!!Be smart
costax1654x
22/4/2020
11:15
Shnuckums Costa der der move on
knowing
22/4/2020
11:14
This is now 'in play'. The days of tiny volumes and drifting down are gone.
on target
22/4/2020
11:13
COVID-19 Project Initiated

Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for deadly blood diseases, is deploying its groundbreaking research and technologies to develop potential treatments for COVID-19.

Concurrently.. Hemogenyx will aim to develop and commercialize a test that could identify people with potentially high/low risk of severe illness caused by the virus.

on target
22/4/2020
11:11
Read the RNS
costax1654x
Chat Pages: Latest  106  105  104  103  102  101  100  99  98  97  96  95  Older

Your Recent History

Delayed Upgrade Clock